LSE:HLN 5 January 2026 - 22 April 2026

Haleon shares were down 0.5% at 370.6 pence by 0849 GMT, extending a two-day decline and lagging a firmer wider market, data showed. Britain’s FTSE 100 was up about 0.6% at the same time. Haleon opened at 371.7 pence and traded between 370.5 and 372.2 pence, with about 229,000 shares changing hands early in the session.

Haleon shares dipped on Monday, edging toward the low end of their range after a quiet start. The stock fell 1.2% to 375.4 pence, following a Friday close of 379.8 pence. It kicked off at 379.3 and fluctuated between 375.36 and 379.3, with roughly 519,000 shares traded in the early session.

On Friday, Barclays upgraded Haleon to “overweight” and raised its price target, putting the London-listed consumer health company in focus heading into next week. The shares closed up 1.70 pence, or 0.45%, after fluctuating between 377.8p and 384.8p, with around 16.9 million shares changing hands, according to Hargreaves Lansdown. Barclays kept a neutral stance on the broader consumer staples sector but also raised L’Oréal and reaffirmed “overweight” ratings on Unilever and Reckitt.